Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET.
about
Neurobiological mechanisms of placebo responsesPersonalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challengesNeurological diseases and painCognitive and emotional control of pain and its disruption in chronic painBrain imaging of pain: state of the art.A Functional Approach to Deconvolve Dynamic Neuroimaging DataImaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Capturing brain metrics of neuropathic pain using nuclear magnetic resonance.EFNS guidelines on neuropathic pain assessment: revised 2009.Cerebral cortex modulation of pain.Can neuroimaging studies identify pain endophenotypes in humans?Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: a pilot study.Imaging of opioid receptors in the central nervous systemTouch Perception Altered by Chronic Pain and by Opioid BlockadeIs there hope for chronic pain and headache?Role of neuroimaging in analgesic drug development.Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls.Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice.Central poststroke pain: an abstruse outcome.Alterations in endogenous opioid functional measures in chronic back painMaldynia: pathophysiology and management of neuropathic and maladaptive pain--a report of the AMA Council on Science and Public Health.Predictive mechanisms linking brain opioids to chronic pain vulnerability and resilience.The delta opioid receptor tool box.Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.Association of Single-Nucleotide Polymorhism C3435T in the ABCB1 Gene with Opioid Sensitivity in Treatment of Postoperative Pain.The automated radiosynthesis and purification of the opioid receptor antagonist, [6-O-methyl-11C]diprenorphine on the GE TRACERlab FXFE radiochemistry module.Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings.Somatic sensation and the insular-opercular cortex: relationship to central pain.The control of tonic pain by active relief learning.
P2860
Q24621444-6027D95E-6468-4171-91FD-70025F2DF2E2Q24627422-15813419-2A5F-4574-97AC-701E9AF87A68Q26822891-C1970BF8-728D-4DB7-B876-BE9118B50126Q27007091-85F5231D-166E-40AA-9C5C-A5BC03F66F0FQ28067180-7FFB9BBE-8891-4B2F-8F43-F14FB9C06CB0Q28834148-C8B17DA2-6C2F-496B-A90C-41325C63FA51Q30657653-AD5EE2FD-0217-4F81-878E-79BCEAFA15F3Q30782991-8066D636-71AC-4F99-975C-3FF6713D707CQ33542772-9694ABBF-DDD6-43A1-A473-18C155FB44A0Q33552223-3F8F4A8B-387E-445C-96D2-10D5516B8157Q33815125-099E46CB-ECD3-443A-9A63-F4C373D94919Q36467531-E9024891-5C4D-49E8-9B89-9ABED47C7E17Q36633126-06BC48B7-C46F-40AE-BE9D-1CCF5E3A271BQ36670848-614C3C6C-D649-436A-B28C-72179CE9A647Q36947170-20B74818-0180-42DF-848B-F74EAC0882CCQ37036818-4ADE5116-AB4F-4B40-991E-34E88BE111CBQ37064951-579711DF-1F10-4203-B1E2-E75E22A1F160Q37077524-0EE41F17-67F2-48DE-834F-E0E687B58C0DQ37095315-3F8F0737-AAE4-4D4D-8417-F8B3EA8949A6Q37165504-72E21BE9-D1BC-4B8B-9DBC-C90686C0826DQ37806318-C07282DD-5334-4393-9494-479B5F9995FCQ38690157-5A783105-AF36-4509-810F-7E13AA49A3C0Q38736977-B9F50532-D3C4-4D42-82F8-48E0D8246C04Q41783954-B89BF8CB-6C6B-432A-A30E-F4D2E439B9B8Q43069916-E856DEC1-A564-485B-A473-C59CCB1F9C6BQ44341580-8966A9F4-C80A-47FA-BB8B-BC20AE8DFD42Q44344263-5EA57363-811D-475F-B8A0-4BA477A86123Q47097600-FF7A9609-E315-4BAB-82EB-59B22C6F44D9Q48518306-A5B63AE2-E125-45FC-B8CD-32760A674838Q50421812-61149CB3-199C-4559-87A6-18103D1B0AE9
P2860
Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET.
description
2004 nî lūn-bûn
@nan
2004 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@en
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@nl
type
label
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@en
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@nl
prefLabel
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@en
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@nl
P2093
P2860
P1476
Cerebral decreases in opioid r ...... diprenorphine binding and PET.
@en
P2093
Anthony K P Jones
Hiroshi Watabe
Terry Jones
Vin J Cunningham
P2860
P304
P356
10.1016/J.EJPAIN.2003.11.017
P577
2004-10-01T00:00:00Z